To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease

Exclusion Criteria

• •Positive stool test for pathogenic bacteria including Clostridium difficile or O\&P.
• •Confirmed intestinal stricture with obstructive-like clinical symptoms.
• •Bowel resection within the previous 6 months.
• •Change in medical therapy: must have been on a stable dose of
• •* corticosteroids (prednisone or prednisolone) less than or equal to 20 mg per day for 2 weeks prior to screening,
• •* budesonide less than or equal to 9 mg per day for 2 weeks prior to screening,
• •* 5-aminosalicylates for 2 weeks prior to screening, and
• •* immunomodulators for 6 weeks prior to screening.
• •Taking greater than 20 mg per day of a corticosteroid (prednisone or prednisolone) or greater than 9 mg of budesonide.
• •Received biologic therapy in past 2 years.
• •Diagnosis of one or more co-morbid condition (s) requiring medical or surgical therapy that may affect bowel function, gastrointestinal symptoms.
• •Serious infection in the 3 months prior to enrollment.
• •Allergy or intolerance to beef or to any ingredient used in the product.
• •Participated in an investigational drug or device study within 30 days.
• •Does not have access to the internet.
• •Taken EnteraGam®